September 23, 2021
Pharmaceutical Temperature Controlled Packaging Solutions

Pharmaceutical Temperature Controlled Packaging Solutions Market Size | Insight 2020 to 2027

The global pharmaceutical temperature controlled packaging solutions market value is expected to reach US$ 6.41 Billion by the end of 2027. The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global pharmaceutical temperature controlled packaging solutions market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

The global pharmaceutical temperature controlled packaging solutions market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the pharmaceutical temperature controlled packaging solutions industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

Pharmaceuticals temperature-controlled packaging solution is an imperative tool in plummeting the hazard and upholding quality of product during the supply chain process by steadying internal temperature. This system benefits to protect shipments across each aspect of the medical supply chain. Some of the foremost application areas of temperature-controlled packaging solutions include inactive pharmaceutical ingredients with balanced temperature, vaccines, biological products and samples, clinical trials, and medical products with detailed timeline necessities.

Temperature-controlled packaging is a vital aspect of the pharmaceutical supply chain, nonetheless is frequently underestimated. It encompasses many components; which all must interrelate in the way they were intended to for temperature to be preserved. Countless influences impact product temperatures and duration, such as heat transfer by conduction, convection and altering external temperatures, contradictory conditioning necessities, masses of diverse temperatures trying to match, phase change materials (PCM) and ice packs. Temperature-controlled packaging solutions are essential to reduce risk and sustaining product integrity from production to the patient by steadying internal temperature irrespective of external environment.

Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1163

Report Highlights

  • In 2019, reusable temperature controlled pharmaceutical solution dominated the global market with around 74% share in terms of revenue
  • Temperature-sensitive pharmaceutical applications led the global pharmaceutical temperature-controlled solution market with more than 65% share in 2019. The effort of addressing more and more patients present in distant locations is predictable to support the requirement for pharmaceuticals temperature-controlled packaging solutions across the world
  • The necessity for improved handling of temperature-sensitive pharmaceutical products has caused in augmented research for more cutting-edge temperature-controlled packaging insulation materials

Growth Factors

Implementation of novel high-performance convection systems that are well-organized for warehousing and supply of pharmaceutical products is anticipated to provide novel growth prospect to the pharmaceutical temperature-controlled packaging solutions industry. Increasing practice of vacuum panel insulation along with the phase change materials can augment the life of warehoused pharmaceutical product. Consequently, the intensifying adoption of such progressive technologies in the pharmaceutical sector is projected to subsidize the growth of the market worldwide.

Emphasis of pharmaceutical manufacturer is budding to manufacture drugs and therapies for rare diseases. These drugs are consisting of high-value ingredients and have small shelf lives as outcome of which they need stringent temperature-controlled environment. Thus, this is predictable to support the ultra-low temperature range packaging solutions. Temperature controlled pharma packaging solutions will endure to see a sturdier influence of regulations, seeing the nature of products to be shipped and packed. Furthermore, the demand for quality and compliance is rising at a greater rate than innovation. Several market participants are emphasizing towards reinforced composite materials with stability and high thermal protection to set their products apart from the rivalry.

Regional Snapshots

North America is predicted to occupy major stake in the global pharmaceutical temperature-controlled packaging solutions market. This region is likely to have a pool of large market players and more usage of pharmaceutical temperature-controlled products in the Canada and U.S. Further, the Asia Pacific excluding Japan (APEJ) region is expected to observe high growth latent for pharmaceutical temperature-controlled packaging solutions. Demand for temperature-controlled packaging solutions in the healthcare sector is anticipated to eyewitness the strongest growth. Wide-ranging application reach of the pharmaceutical sector is propelling the demand for the product suggestively.

The U.S. Food and Drug Administration has quantified thermal necessities for handling, transportation, and storage of the drugs. These containers address the hygiene and thermal obligation of the healthcare products such as vaccines, drugs, blood, and organs. Over the past couple of years, international health organizations such as the World Health Organization (WHO) have been highlighting the reducing of vaccine waste. Besides, cumulative initiatives to monitor vaccine wastage are anticipated to bolster the demand for the product in the future.

Swift escalation in the commonness of chronic diseases, swelling number of clinical trials in the nations such as India and China, and rising demand for temperature sensitive products will profoundly subsidize to the growth of the pharmaceutical temperature-controlled packaging solutions market within APEJ region.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global pharmaceutical temperature controlled packaging solutions market are as follows:

  • Pelican Biothermal
  • Cryopak
  • Sonoco Products Company
  • Envirotainer
  • DS Smith Pharma
  • Cold Chain Technologies
  • World Courier
  • Intelsius
  • CSafe
  • Softbox Systems
  • Skycell
  • Va-Q-tec AG
  • Sofrigam

Market Segmentation

By Product

  • Reusable Solutions
  • Single Use Solutions

By Application

  • Temperature-Sensitive Pharmaceuticals
  • Vaccines
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global pharmaceutical temperature controlled packaging solutions market. It examines trends and factors influencing demand for pharmaceutical temperature controlled packaging solutions globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for pharmaceutical temperature controlled packaging solutions across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on pharmaceutical temperature controlled packaging solutions. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global pharmaceutical temperature controlled packaging solutions market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical temperature controlled packaging solutions are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, By Product

7.1. Pharmaceutical Temperature Controlled Packaging Solutions Market, by Product Type, 2020-2027
7.1.1. Reusable Solutions
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Single Use Solutions
7.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, By Application

8.1. Pharmaceutical Temperature Controlled Packaging Solutions Market, by Application, 2020-2027
8.1.1. Temperature-Sensitive Pharmaceuticals
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Vaccines
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)

Chapter 10. Company Profiles

10.1. Pelican Biothermal
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Cryopak
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Sonoco Products Company
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Envirotainer
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. DS Smith Pharma
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Cold Chain Technologies
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. World Courier
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Intelsius
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. CSafe
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Softbox Systems
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Skycell
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Va-Q-tec AG
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Sofrigam
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1163

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *